Thanks Candid, if you could point me to other small cap Biotechs that are priced fairly according to your valuation model I would be more inclined to consider it a legitimate methodology.
To be frank, I think your model is incompatible with this end of the market based on my experience and knowledge. Would love to be proven otherwise with some data.
OSX Price at posting:
46.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
